Sempio, Cristina
Klawitter, Jelena
Jackson, Matthew
Freni, Francesca
Shillingburg, Ryan
Hutchison, Kent
Bidwell, L. Cinnamon
Christians, Uwe
Klawitter, Jost
Funding for this research was provided by:
Colorado Department of Public Health and Environment (96947)
National Institute on Drug Abuse (DA039707)
Article History
Received: 3 January 2021
Revised: 2 March 2021
Accepted: 8 March 2021
First Online: 5 April 2021
Declarations
:
: The authors declare no competing interests.
: The clinical study was approved by the University of Colorado Boulder Institutional Review Board and the primary outcomes have been published previously [CitationRef removed]. The study was registered as an observational study in ExternalRef removed (NCT03522103).
: Blank human K2EDTA plasma was received from Bioreclamation IVT (Westbury, NY, USA) and charcoal-stripped human plasma was received from BioCheMed (Winchester, VA, USA).